We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Tackles Crisis Response in Wake of GAO Criticism
FDA Tackles Crisis Response in Wake of GAO Criticism
December 6, 2010
The FDA is taking steps to ensure it can respond to financially motivated adulteration that can affect device safety while maintaining appropriate relationships with industry experts, a Government Accountability Office (GAO) report says.